Thursday - August 28, 2025
University of Queensland: World-First Immunotherapy Trial to Treat Type 1 Diabetes
April 29, 2025
BRISBANE, Australia, April 29 -- The University of Queensland issued the following news:

* * *

World-first immunotherapy trial to treat Type 1 diabetes

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially revolutionary immunotherapy drug to treat Type 1 diabetes.

Professor Ranjeny Thomas AM from UQ's Frazer Institute has led the development of a targeted immunotherapy drug, ASIT . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products